143 related articles for article (PubMed ID: 9339397)
1. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
[TBL] [Abstract][Full Text] [Related]
2. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo Y; Kudo E; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1998 Jul; 51(7):488-93. PubMed ID: 9755432
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
[TBL] [Abstract][Full Text] [Related]
7. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
Hatano K; Yokota Y; Hanaki H; Sunakawa K
Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
[TBL] [Abstract][Full Text] [Related]
8. [Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA].
Utsui Y; Ishii C; Abe T; Kakuta M; Ohya S
Jpn J Antibiot; 1999 Mar; 52(3):268-77. PubMed ID: 10367264
[TBL] [Abstract][Full Text] [Related]
9. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Feb; 46(2):115-22. PubMed ID: 8331771
[TBL] [Abstract][Full Text] [Related]
10. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
[TBL] [Abstract][Full Text] [Related]
11. Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
Kobayashi Y
J Infect Chemother; 2005 Oct; 11(5):259-61. PubMed ID: 16258825
[TBL] [Abstract][Full Text] [Related]
12. [In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus].
Maekawa M; Takahashi K; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):440-5. PubMed ID: 12378872
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Kinoshita S; Kumagai S
Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
[TBL] [Abstract][Full Text] [Related]
15. [Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Fukabori T; Mizobuchi K; Nakamura M; Takizawa H; Takashina R; Fujita Y
Jpn J Antibiot; 1997 Apr; 50(4):299-305. PubMed ID: 9192247
[TBL] [Abstract][Full Text] [Related]
16. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Fukuoka T; Inoue H; Abe T; Ohya S
Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
[TBL] [Abstract][Full Text] [Related]
17. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
[TBL] [Abstract][Full Text] [Related]
18. [Bactericidal activity of biapenem against various bacteria].
Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial activities of meropenem against clinically isolated strains].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
